Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30421% above fair value
$23.53+0.06 (+0.26%)
Close on Nov 17, 2026Market cap $3.65BP/E –Yield –
Zai Lab total assets
Total assets on the balance sheet at the end of each period.
Zai Lab's total assets was $1.07B at Jun 30, 2026. For fiscal 2025 it was $1.17B, down 1.1% from the year before. The highest annual figure on record is $1.61B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | -1.1% |
| FY2024 | Dec 31, 2024 | $1.19B | +14.4% |
| FY2023 | Dec 31, 2023 | $1.04B | -15.1% |
| FY2022 | Dec 31, 2022 | $1.22B | -24.2% |
| FY2021 | Dec 31, 2021 | $1.61B | +24.1% |
| FY2020 | Dec 31, 2020 | $1.30B | +265.4% |
| FY2019 | Dec 31, 2019 | $355.15M | +17.6% |
| FY2018 | Dec 31, 2018 | $301.99M | +21.0% |
| FY2017 | Dec 31, 2017 | $249.63M | +180.8% |
| FY2016 | Dec 31, 2016 | $88.91M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.07B | -7.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.10B | -6.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.17B | -1.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.16B | +17.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.16B | +17.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.17B | +18.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.19B | +14.4% |
| Q3 FY2024 | Sep 30, 2024 | $985.35M | -5.6% |
| Q2 FY2024 | Jun 30, 2024 | $987.37M | -10.8% |
| Q1 FY2024 | Mar 31, 2024 | $988.44M | -15.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.04B | -15.1% |
| Q3 FY2023 | Sep 30, 2023 | $1.04B | -19.6% |
| Q2 FY2023 | Jun 30, 2023 | $1.11B | -22.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.17B | -22.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.22B | -24.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.30B | -24.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.42B | -25.1% |
| Q1 FY2022 | Mar 31, 2022 | $1.50B | +32.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.61B | +24.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.73B | +215.2% |
| Q2 FY2021 | Jun 30, 2021 | $1.90B | +433.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.13B | +188.9% |
| Q4 FY2020 | Dec 31, 2020 | $1.30B | +329.7% |
| Q2 FY2020 | Jun 30, 2020 | $548.21M | +119.6% |
| Q4 FY2019 | Dec 31, 2019 | $355.15M | +299.5% |
| Q3 FY2019 | Sep 30, 2019 | $391.63M | – |
| Q4 FY2018 | Dec 31, 2018 | $301.99M | – |
| Q4 FY2017 | Dec 31, 2017 | $249.63M | – |
| Q4 FY2016 | Dec 31, 2016 | $88.91M | – |
See a number that looks wrong?